Race Oncology Limited (RAONF)
OTCMKTS
· Delayed Price · Currency is USD
1.220
0.00 (0.00%)
At close: Jul 11, 2024
Race Oncology Revenue
In the fiscal year ending June 30, 2024, Race Oncology had annual revenue of 4.00M AUD with 27.73% growth.
Revenue
4.00M AUD
Revenue Growth
+27.73%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
148.80M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 4.00M | 869.09K | 27.73% |
| Jun 30, 2023 | 3.13M | 2.43M | 342.83% |
| Jun 30, 2022 | 707.81K | 320.42K | 82.71% |
| Jun 30, 2021 | 387.39K | 228.01K | 143.07% |
| Jun 30, 2020 | 159.37K | -69.13K | -30.25% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |